This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on advances in high throughput enzymatic DNA synthesis technologies which are being adopted across multiple lifescience and healthcare applications. The applications of gene circuits in drug discovery and therapeutics development has also been captured with innovations highlighting the use of engineered stem cells for drug discovery, and programmable cell and gene therapies amongst others. Engineered synthetic cells, microbes for antibiotic production and cell-free biosensors for environment applications are some of the other synbio related innovations covered in this issue.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
GROWTH PIPELINE DIALOG™
Take your first step towards achieving growth-centric solutions with our
Growth Pipeline Dialog™. Speak to our industry experts in a complimentary open discussion that will spark innovative thinking and growth opportunities that will benefit your organization.